Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

PAD regimen

View Patient Information
A chemotherapy regimen containing bortezomib, doxorubicin and dexamethasone regimen used in the treatment of plasma cell myeloma.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:bortezomib-doxorubicin-dexamethasone regimen
bortezomib/ dexamethasone/doxorubicin
bortezomib/doxorubicin/dexamethasone regimen
PS-341/Adriamycin/dexamethasone regimen
Velcade/adriamycin/dexamethasone regimen
Abbreviation:PAD
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search